Andrew Schachter, CEO/Founder
As Chief Executive Officer and Founder of Axiom Real-Time Metrics, Andrew Schachter provides the visionary leadership integral to the company’s more than 10 years of eClinical technology and services success.
The pairing of his expertise and deep knowledge of clinical research with his passion for user friendly technology and end user engagement has been critical to Axiom’s growth into a recognized innovator and leader in the eClinical solutions space.
Andrew founded Axiom in 2001, launching the company with a focus on registries and working with global clients including Roche, Takeda and Astellas. By 2003, the technology had evolved to a full registry and EDC offering with clients from start-ups to big pharma. In 2006, Andrew pivoted the business to focus exclusively on small-to-mid size life sciences companies and their unique requirements, providing powerful eClinical [EDC, DM, IWRS, Reporting] technology and Data Management professional services.
Axiom has redefined the focus of eClinical technology away from the basics of EDC and data management to the inclusive trend of encompassing the entire study. This has lead to Axiom’s development of sophisticated and time-saving technology such as inventory management, payment management, and integrated IWRS/randomization. At Axiom, Andrew has directed teams to push the technology and professional services forward in order to offer a completely unified platform for the conduct of a trial or registry.
Since 2001, Axiom’s Fusion eClinical Suite has been used to run hundreds of studies across a wide range of therapeutic areas, from small phase I studies to global Phase IIIs and registries. Some of Axiom’s current clients include Anika Therapeutics, Precision Biologics, 480 Biomedical, Vicus Therapeutics, and many more.
Prior to founding Axiom, Andrew was a VP with Synapse Group, Managing Director at US Interactive, and Director, Interactive Strategy & Development at TBWA\Chiat\Day. Axiom is the second company that Andrew founded. The first company, Think Interactive, was sold to US Interactive in 2000.
With an exceptional group of dedicated team members, Axiom continues to deliver services to an ever expanding roster of biotech, device, CROs and diagnostic clients with the most comprehensive, unified suite of eClinical tools and services in the market today.
Follow Andrew’s personal twitter feed via Schachter_to